Full Episode
Friday, Mar 20
PBS NewsHour
  • Episodes
  • Podcasts
  • Newsletters
  • The Latest
  • Politics
    Politics
    • Brooks and Capehart
    • Politics Monday
    • Supreme Court
  • Arts
    Arts
    • CANVAS
    • Poetry
    • Now Read This
  • Nation
    Nation
    • Supreme Court
    • Race Matters
    • Essays
    • Brief But Spectacular
  • World
    World
    • Agents for Change
    • Compass Points
  • Economy
    Economy
    • Making Sen$e
    • Paul Solman
  • Science
    Science
    • The Leading Edge
    • ScienceScope
    • Basic Research
    • Innovation and Invention
  • Health
    Health
    • Horizons
    • Long-Term Care
  • Education
    Education
    • Teachers' Lounge
    • Student Reporting Labs
  • For Teachers
    Education
    • Newshour Classroom
  • About
    • Feedback
    • Funders
    • Support
    • Jobs
PBS News

Get news alerts from PBS News

Turn on desktop notifications?

FDA

  • Full Episodes
  • Podcasts
  • Newsletters
  • Live
FILE PHOTO: Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy in London

Health Mar 14

What are peptides, and are they safe? Here's what to know

By Grace Abels, PolitiFact

Health Mar 10

An illustration photo shows Leucovorin in Schwenksville
FDA finds little evidence that the generic drug leucovorin can help people with autism

FDA officials say evidence only supports the drug's use in patients with a specific genetic disorder.

By Matthew Perrone, Associated Press

Nation Mar 09

FILE PHOTO: A injection pen of Novo Nordisk's weight-loss drug Wegovy is shown in this photo illustration in Oslo
Novo Nordisk drops lawsuit against Hims & Hers over off-brand weight loss medications, enter collaboration

The companies on Monday announced a partnership in which Hims & Hers will sell Novo Nordisk's medications at "self-pay prices."…

By Michelle Chapman, Associated Press

Health Jan 18

FILE PHOTO: U.S. President Donald Trump makes an announcement at the White House, in Washington, D.C.
FDA's new expedited drug program raises legal questions and concerns

The FDA commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the agency.

By Matthew Perrone, Associated Press

Health Jan 11

FILE PHOTO: Safeway Pharmacist Sonya Safaie works at a Safeway Pharmacy in Great Falls, Virginia
Watch 5:15
Investigation raises concerns about lack of FDA quality testing for generic drugs

By some estimates, about 90% of prescriptions in the U.S. are filled with generic drugs. The Food and Drug Administration says that all agency-approved generic drugs “have the same high quality” as brand-name drugs, but a ProPublica investigation found that…

By John Yang, Andrew Corkery

Dec 01

New lens approved by FDA promises to slow nearsightedness in children

By Matthew Perrone, Associated Press

The lenses use concentric rings to refocus light, potentially preventing severe eye issues like cataracts and retinal detachment.

Continue reading

Nov 23

What to know about menopause hormone therapy after FDA removed 'black box' warnings

By Grace Abels, PolitiFact

The FDA removed safety warnings from several hormone drugs used to treat menopause symptoms. Here’s what you need to know about these treatments before your next doctor's appointment.

Continue reading

Nov 10

Watch 8:47
FDA head explains decision to drop 'black box' warnings from menopause hormone treatment

By Ali Rogin, Courtney Norris

The FDA announced it would begin asking drug companies to remove so-called “black box” warnings for hormones prescribed to treat symptoms of menopause. The FDA says the warning has dissuaded generations of women from taking advantage of the medication that…

Continue watching

Nov 09

What to know about the FDA's recall of the blood pressure drug prazosin

By C. Michael White, The Conversation

A generic blood pressure drug called prazosin, made by Teva Pharmaceuticals, is being recalled by the Food and Drug Administration because it contains elevated levels of cancer-causing chemicals called nitrosamines.

Continue reading

Nov 03

Top FDA drug regulator resigns after officials probe 'serious concerns' about his conduct

By Matthew Perrone, Associated Press

The head of the Food and Drug Administration’s drug center abruptly resigned Sunday amid concerns about his personal conduct.

Continue reading

Jump to the First Page Previous Page
1 2 3 4 5 6 7 8 9 36
Next Page Jump to the Last Page

Support Provided By: Learn more

Evergreen_WebAd_Sidebar_DonateNow

Educate your inbox

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Form error message goes here.

Thank you. Please check your inbox to confirm.

Full Episode
Friday, Mar 20
  • Cunard
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You
  • Friends of the News Hour
PBS News

© 1996 - 2026 NewsHour Productions LLC. All Rights Reserved.

PBS is a 501(c)(3) not-for-profit organization.

Sections

  • The Latest
  • Politics
  • Arts
  • Nation
  • World
  • Economy
  • Science
  • Health
  • Education

About

  • About Us
  • TV Schedule
  • Press
  • Feedback
  • Funders
  • Support
  • Newsletters
  • Podcasts
  • Jobs
  • Privacy
  • Terms of Use

Stay Connected

  • Facebook
  • YouTube
  • Instagram
  • X
  • TikTok
  • Threads
  • RSS

Subscribe to Here's the Deal with Lisa Desjardins

Form error message goes here.

Thank you. Please check your inbox to confirm.

Support our journalism

Support for News Hour Provided By

  • Cunard
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You